Pimecrolimus
Overview
Pimecrolimus is an immunosuppressant used topically in the treatment of atopic dermatitis. It acts by inhibiting calcineurin, thereby reducing T-cell activation and the release of inflammatory cytokines.
API suppliers (4)
Suppliers of Pimecrolimus evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 4 suppliers.
2 of 4 hold a GMP certificate on record in the EU or UK registers
- Biocon LimitedIndia1 active DMF
- CONCORD BIOTECH LTDIndia1 active DMF GMP on record
- CURIA ITALY SRLItaly1 active DMF GMP on record
- CHENGDU YACHT BIOTECHNOLOGY CO LTD1 active DMF
Therapeutic areas
Do you supply Pimecrolimus? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.